Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Research article · 3 May 2021 Short communication · 30 Apr 2021 Oncology research on men at high risk for prostate cancer
Three gatherings of men are at high danger of creating prostate malignant
Mini review · 30 Mar 2021 "Complementary Contribution of Positron Emission Tomography "PET" and MRI in the Management Of Prostate Cancer in Initial Extension Assessment and in Biological Relapse"
Introduction: Prostate cancer is currently the second leading cause of cancer death in men in Europe and developed countries, with about 300,000 new cases diagnosed each year. The respective ... multipara metric MRI and…
Research article · 26 Mar 2021 Evaluation of selected proinflammatory factors, angiogenesis and lymphangiogenesis as potential markers of early tumor recurrence in patients undergoing surgical treatment for prostate cancer
Introduction: Up to a half of patients after radical prostatectomy due to prostate cancer have biochemical recurrence, i.e., PSA concentrations >0.2 ng/ml. In most patients, biochemical recurrence does ... about one…
Short communication · 26 Feb 2021 Precision management in castration resistant prostate cancer (CRPC): A theranostic approach
therapy with the same vector. This concept is utilized in few malignancies and prostate cancer is one of them. PSMA (prostrate specific membrane antigen) expression in normal and other tumor ... less than prostate…
Short communication · 25 Feb 2021 Understanding Reported Outcomes in a New Home-Based Rehabilitation Programmed For Prostate Cancer Patients
The most ideal exercise plan for men with prostate disease (PC) accepting
Case report · 12 Feb 2021 Isolated Peritoneal Carcinomatosis and Possible Ureteral Mestas tases Secondary to Unknown Prostate Cancer
Peritoneal carcinomatosis secondary to prostate cancer is extremely rare, especially in the absence of bone metastasis, with three cases published to date.We present an 87-year-old man with
Review article · 5 Feb 2021 High dose rate brachytherapy for prostate cancer: rationale, current applications and clinical outcome
been enjoying rapid acceptance as a treatment modality offered to selected prostate cancer patients devoid of risk group, employed either alone or in combination with external beam radiation therapy (EBRT ... highly…
Review article · 30 Jan 2021 Are Genetic Alterations an Important Factor in the Development and Progression of Prostate Cancer?
Prostate cancer (PC) is the second most common cancer in the UK and the most common cancer in males. The aetiology of PC is poorly understood and the molecular events
Editorial · 27 Jan 2021 Editorial Note on Metastatic Prostate Cancer
fear among the peoples of any age group. In practice, though, most cases of prostate cancer metastasis occur in the lymph nodes and the bones. Prostate cancer metastasis occurs when ... lymphatic system or the…
Editorial · 2021 Dietary factors and development of prostate cancer
Short communication · 2021 Prostate Cancer of Epigenome and Genome
Commentary · 2021 Estimation Risk of Prostate Cancer Metastasis, Death by Genomic Test
Commentary · 2021 A Mini on Hormone Therapy for Prostate Cancer
Conference abstract · 2021 Detection of tumor-related DNA methylation biomarkers in liquid biopsies from metastatic castration resistant prostate cancer patients to improve treatment decisions
emerging as an important source of minimally invasive biomarkers, especially in metastatic castration resistant prostate cancer (mCRPC), where tumors are often inaccessible for biopsy based strategies. In particular…
Short communication · 30 Nov 2020 Pro-inflammatory cytokine and chemokines genes drive prostate cancer progression and metastasis: molecular mechanism update and the science that underlies racial disparity
reported prostate cancer grows more rapidly in African American men (AAM) than in European American men (EAM) and/or can have earlier transformation from latent to aggressive prostate cancer
Short communication · 25 Nov 2020 Needs to understand Common Things About Prostate Cancer
second most common cause of death from cancer in the United States is prostate cancer. The Prostate Working Group (PWG) Cancer Intervention and Surveillance Modeling Network (CISNET) was established ... address a wide…
Case series · 15 Nov 2020 177Lu-PSMA Therapy an Alternative Therapy for Metastatic Castrate Resistant Prostate Cancer with Suboptimal Response: Are we ready for it
177Lu-PSMA) is used as the last treatment option in metastatic castrate resistant prostate cancer (mCRPC). We present two cases of mCRPC with bone involvement to see the response
Review article · 3 Nov 2020 Usefulness of Prostate Specific Antigen Density in Prostate Cancer Detection among Men with PSA of 4-10 ng/ml
Background: Prostate cancer (CaP) is a common malignancy in men and late presentation is still an issue. The discovery of PSA has revolutionized the diagnosis of CaP however has difficulties ... Objectives: To determine…
Conference abstract · Nov 2020 Zero-Inflated Models for Assessing the Effects of Supplements on Reducing Prostate Cancer Incidence
Data with many zeros are often encountered in medical and public health studies. In prostate cancer studies, for example, the frequency of use of nutritional supplements by black ... strong evidence from literature that…
Research article · 29 Oct 2020 A Novel Research Area of PCDH-PC in Inhibition of Prostate Cancer Cells Invasion and Metastasis through Epithelial: Mesenchymal Transition
effects of Protocadherin-PC (PCDH-PC) gene expression on Epithelial Mesenchymal Transition (EMT) in prostate cancer cells. Methods: Western blot analysis, morphological analysis, and in vitro wound closure assay were…

